Multivariate analysis for the probability of achieving a complete cytogenetic response on imatinib by 3 months of therapy
| Factor . | Estimate of coefficient . | Estimate of odds ratio . | P . |
|---|---|---|---|
| Dose 400 mg/day (baseline, 800 mg/day) | −1.395 | 0.25 | < .001 |
| Higher PB blasts, % | −0.59 | 0.55 | < .001 |
| Lower hemoglobin | 0.29 | 1.34 | .001 |
| Factor . | Estimate of coefficient . | Estimate of odds ratio . | P . |
|---|---|---|---|
| Dose 400 mg/day (baseline, 800 mg/day) | −1.395 | 0.25 | < .001 |
| Higher PB blasts, % | −0.59 | 0.55 | < .001 |
| Lower hemoglobin | 0.29 | 1.34 | .001 |